Do analysts rate ALPS or NKTX?

Nkarta has a consensus target price of $11.20, indicating a potential upside of 325.86%. Given Nkarta's stronger consensus rating and higher possible upside, analysts plainly believe Nkarta is more favorable than ALPS Group Inc Ordinary Share. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALPS Group Inc Ordinary Share 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nkarta 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86

Is ALPS or NKTX more profitable?

ALPS Group Inc Ordinary Share's return on equity of 0.00% beat Nkarta's return on equity. Company Net Margins Return on Equity Return on Assets ALPS Group Inc Ordinary Share N/A N/A N/A Nkarta N/A -39.64% -30.45%

Do analysts prefer CRBU or ALPS?

Caribou Biosciences currently has a consensus price target of $7.75, indicating a potential upside of 369.70%. Given Caribou Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe Caribou Biosciences is more favorable than ALPS Group Inc Ordinary Share. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Caribou Biosciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.80 ALPS Group Inc Ordinary Share 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer ALPS or MOLN?

Molecular Partners has a consensus price target of $8.38, indicating a potential upside of 88.20%. Given Molecular Partners' stronger consensus rating and higher possible upside, analysts plainly believe Molecular Partners is more favorable than ALPS Group Inc Ordinary Share. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALPS Group Inc Ordinary Share 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Molecular Partners 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is ALPS or MOLN more profitable?

ALPS Group Inc Ordinary Share's return on equity of 0.00% beat Molecular Partners' return on equity. Company Net Margins Return on Equity Return on Assets ALPS Group Inc Ordinary Share N/A N/A N/A Molecular Partners N/A -66.62% -54.85%

Do analysts recommend ALPS or MDWD?

MediWound has a consensus price target of $33.00, suggesting a potential upside of 159.84%. Given MediWound's stronger consensus rating and higher possible upside, analysts clearly believe MediWound is more favorable than ALPS Group Inc Ordinary Share. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALPS Group Inc Ordinary Share 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 MediWound 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts recommend ALPS or OKUR?

OnKure Therapeutics has a consensus target price of $17.50, suggesting a potential upside of 360.53%. Given OnKure Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe OnKure Therapeutics is more favorable than ALPS Group Inc Ordinary Share. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALPS Group Inc Ordinary Share 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 OnKure Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is ALPS or OKUR more profitable?

ALPS Group Inc Ordinary Share's return on equity of 0.00% beat OnKure Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets ALPS Group Inc Ordinary Share N/A N/A N/A OnKure Therapeutics N/A -49.01% -45.77%

ALPS Group Inc Ordinary Share (ALPS) Competitors

$0.42 +0.11 (+33.39%)

As of 03:59 PM Eastern

Compare

ALPS vs. NKTX, CRBU, MOLN, MDWD, and OKUR

Should you buy ALPS Group Inc Ordinary Share stock or one of its competitors? ALPS Group Inc Ordinary Share's main competitors and comparable companies include Nkarta (NKTX), Caribou Biosciences (CRBU), Molecular Partners (MOLN), MediWound (MDWD), and OnKure Therapeutics (OKUR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does ALPS Group Inc Ordinary Share compare to Nkarta?

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) and Nkarta (NASDAQ:NKTX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

ALPS Group Inc Ordinary Share has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market. Comparatively, Nkarta has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

In the previous week, ALPS Group Inc Ordinary Share and ALPS Group Inc Ordinary Share both had 2 articles in the media. Nkarta's average media sentiment score of 1.78 beat ALPS Group Inc Ordinary Share's score of 0.45 indicating that Nkarta is being referred to more favorably in the news media.

Company	Overall Sentiment
ALPS Group Inc Ordinary Share	Neutral
Nkarta	Very Positive

ALPS Group Inc Ordinary Share has higher revenue and earnings than Nkarta. Nkarta is trading at a lower price-to-earnings ratio than ALPS Group Inc Ordinary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALPS Group Inc Ordinary Share	$4.86M	14.38	-$2.01M	$0.33	1.27
Nkarta	N/A	N/A	-$104.08M	-$1.57	N/A

Nkarta has a consensus target price of $11.20, indicating a potential upside of 325.86%. Given Nkarta's stronger consensus rating and higher possible upside, analysts plainly believe Nkarta is more favorable than ALPS Group Inc Ordinary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALPS Group Inc Ordinary Share	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nkarta	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

27.9% of ALPS Group Inc Ordinary Share shares are owned by institutional investors. Comparatively, 80.5% of Nkarta shares are owned by institutional investors. 0.8% of ALPS Group Inc Ordinary Share shares are owned by insiders. Comparatively, 9.8% of Nkarta shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

ALPS Group Inc Ordinary Share's return on equity of 0.00% beat Nkarta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ALPS Group Inc Ordinary Share	N/A	N/A	N/A
Nkarta	N/A	-39.64%	-30.45%

Summary

Nkarta beats ALPS Group Inc Ordinary Share on 8 of the 14 factors compared between the two stocks.

How does ALPS Group Inc Ordinary Share compare to Caribou Biosciences?

Caribou Biosciences (NASDAQ:CRBU) and ALPS Group Inc Ordinary Share (NASDAQ:ALPS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

Caribou Biosciences has a beta of 2.38, indicating that its stock price is 138% more volatile than the broader market. Comparatively, ALPS Group Inc Ordinary Share has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market.

ALPS Group Inc Ordinary Share has lower revenue, but higher earnings than Caribou Biosciences. Caribou Biosciences is trading at a lower price-to-earnings ratio than ALPS Group Inc Ordinary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caribou Biosciences	$11.16M	15.85	-$148.12M	-$1.08	N/A
ALPS Group Inc Ordinary Share	$4.86M	14.38	-$2.01M	$0.33	1.27

ALPS Group Inc Ordinary Share has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,030.42%. ALPS Group Inc Ordinary Share's return on equity of 0.00% beat Caribou Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caribou Biosciences	-1,030.42%	-89.11%	-62.47%
ALPS Group Inc Ordinary Share	N/A	N/A	N/A

77.5% of Caribou Biosciences shares are held by institutional investors. Comparatively, 27.9% of ALPS Group Inc Ordinary Share shares are held by institutional investors. 8.5% of Caribou Biosciences shares are held by company insiders. Comparatively, 0.8% of ALPS Group Inc Ordinary Share shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Caribou Biosciences and Caribou Biosciences both had 2 articles in the media. Caribou Biosciences' average media sentiment score of 0.63 beat ALPS Group Inc Ordinary Share's score of 0.45 indicating that Caribou Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Caribou Biosciences	Positive
ALPS Group Inc Ordinary Share	Neutral

Caribou Biosciences currently has a consensus price target of $7.75, indicating a potential upside of 369.70%. Given Caribou Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe Caribou Biosciences is more favorable than ALPS Group Inc Ordinary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caribou Biosciences	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
ALPS Group Inc Ordinary Share	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Caribou Biosciences beats ALPS Group Inc Ordinary Share on 10 of the 16 factors compared between the two stocks.

How does ALPS Group Inc Ordinary Share compare to Molecular Partners?

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) and Molecular Partners (NASDAQ:MOLN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

27.9% of ALPS Group Inc Ordinary Share shares are held by institutional investors. Comparatively, 26.6% of Molecular Partners shares are held by institutional investors. 0.8% of ALPS Group Inc Ordinary Share shares are held by insiders. Comparatively, 5.9% of Molecular Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Molecular Partners has a consensus price target of $8.38, indicating a potential upside of 88.20%. Given Molecular Partners' stronger consensus rating and higher possible upside, analysts plainly believe Molecular Partners is more favorable than ALPS Group Inc Ordinary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALPS Group Inc Ordinary Share	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Molecular Partners	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

ALPS Group Inc Ordinary Share's return on equity of 0.00% beat Molecular Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ALPS Group Inc Ordinary Share	N/A	N/A	N/A
Molecular Partners	N/A	-66.62%	-54.85%

ALPS Group Inc Ordinary Share has higher earnings, but lower revenue than Molecular Partners. Molecular Partners is trading at a lower price-to-earnings ratio than ALPS Group Inc Ordinary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALPS Group Inc Ordinary Share	$4.86M	14.38	-$2.01M	$0.33	1.27
Molecular Partners	$5.65M	31.80	-$74.41M	-$1.94	N/A

In the previous week, Molecular Partners had 4 more articles in the media than ALPS Group Inc Ordinary Share. MarketBeat recorded 6 mentions for Molecular Partners and 2 mentions for ALPS Group Inc Ordinary Share. Molecular Partners' average media sentiment score of 1.27 beat ALPS Group Inc Ordinary Share's score of 0.45 indicating that Molecular Partners is being referred to more favorably in the news media.

Company	Overall Sentiment
ALPS Group Inc Ordinary Share	Neutral
Molecular Partners	Positive

ALPS Group Inc Ordinary Share has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market. Comparatively, Molecular Partners has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Summary

Molecular Partners beats ALPS Group Inc Ordinary Share on 9 of the 15 factors compared between the two stocks.

How does ALPS Group Inc Ordinary Share compare to MediWound?

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) and MediWound (NASDAQ:MDWD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

In the previous week, MediWound had 3 more articles in the media than ALPS Group Inc Ordinary Share. MarketBeat recorded 5 mentions for MediWound and 2 mentions for ALPS Group Inc Ordinary Share. ALPS Group Inc Ordinary Share's average media sentiment score of 0.45 beat MediWound's score of 0.34 indicating that ALPS Group Inc Ordinary Share is being referred to more favorably in the media.

Company	Overall Sentiment
ALPS Group Inc Ordinary Share	Neutral
MediWound	Neutral

ALPS Group Inc Ordinary Share has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market. Comparatively, MediWound has a beta of 0.15, meaning that its share price is 85% less volatile than the broader market.

ALPS Group Inc Ordinary Share has a net margin of 0.00% compared to MediWound's net margin of -170.10%. ALPS Group Inc Ordinary Share's return on equity of 0.00% beat MediWound's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ALPS Group Inc Ordinary Share	N/A	N/A	N/A
MediWound	-170.10%	-47.24%	-24.27%

ALPS Group Inc Ordinary Share has higher earnings, but lower revenue than MediWound. MediWound is trading at a lower price-to-earnings ratio than ALPS Group Inc Ordinary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALPS Group Inc Ordinary Share	$4.86M	14.38	-$2.01M	$0.33	1.27
MediWound	$16.96M	9.62	-$23.88M	-$1.80	N/A

27.9% of ALPS Group Inc Ordinary Share shares are held by institutional investors. Comparatively, 46.8% of MediWound shares are held by institutional investors. 0.8% of ALPS Group Inc Ordinary Share shares are held by insiders. Comparatively, 9.2% of MediWound shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

MediWound has a consensus price target of $33.00, suggesting a potential upside of 159.84%. Given MediWound's stronger consensus rating and higher possible upside, analysts clearly believe MediWound is more favorable than ALPS Group Inc Ordinary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALPS Group Inc Ordinary Share	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
MediWound	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

ALPS Group Inc Ordinary Share and MediWound tied by winning 8 of the 16 factors compared between the two stocks.

How does ALPS Group Inc Ordinary Share compare to OnKure Therapeutics?

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) and OnKure Therapeutics (NASDAQ:OKUR) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

ALPS Group Inc Ordinary Share's return on equity of 0.00% beat OnKure Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ALPS Group Inc Ordinary Share	N/A	N/A	N/A
OnKure Therapeutics	N/A	-49.01%	-45.77%

ALPS Group Inc Ordinary Share has a beta of -0.1, suggesting that its share price is 110% less volatile than the broader market. Comparatively, OnKure Therapeutics has a beta of 0.29, suggesting that its share price is 71% less volatile than the broader market.

In the previous week, ALPS Group Inc Ordinary Share and ALPS Group Inc Ordinary Share both had 2 articles in the media. OnKure Therapeutics' average media sentiment score of 1.23 beat ALPS Group Inc Ordinary Share's score of 0.45 indicating that OnKure Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
ALPS Group Inc Ordinary Share	Neutral
OnKure Therapeutics	Positive

OnKure Therapeutics has a consensus target price of $17.50, suggesting a potential upside of 360.53%. Given OnKure Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe OnKure Therapeutics is more favorable than ALPS Group Inc Ordinary Share.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALPS Group Inc Ordinary Share	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OnKure Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

ALPS Group Inc Ordinary Share has higher revenue and earnings than OnKure Therapeutics. OnKure Therapeutics is trading at a lower price-to-earnings ratio than ALPS Group Inc Ordinary Share, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ALPS Group Inc Ordinary Share	$4.86M	14.38	-$2.01M	$0.33	1.27
OnKure Therapeutics	N/A	N/A	-$59.52M	-$3.50	N/A

27.9% of ALPS Group Inc Ordinary Share shares are owned by institutional investors. Comparatively, 91.0% of OnKure Therapeutics shares are owned by institutional investors. 0.8% of ALPS Group Inc Ordinary Share shares are owned by insiders. Comparatively, 2.2% of OnKure Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

OnKure Therapeutics beats ALPS Group Inc Ordinary Share on 7 of the 13 factors compared between the two stocks.

Get ALPS Group Inc Ordinary Share News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALPS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALPS vs. The Competition

Export

Metric	ALPS Group Inc Ordinary Share	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$69.87M	$4.03B	$7.30B	$12.77B
Dividend Yield	N/A	3.63%	2.53%	10.79%
P/E Ratio	1.27	11.42	272.49	24.13
Price / Sales	14.38	1,366.67	626.71	98.17
Price / Cash	N/A	103.64	78.57	53.12
Price / Book	-0.14	16.88	13.14	6.23
Net Income	-$2.01M	-$22.76M	$3.47B	$348.07M
7 Day Performance	55.52%	1.55%	1.38%	0.66%
1 Month Performance	-9.93%	11.71%	8.62%	4.84%
1 Year Performance	N/A	56.88%	25.90%	16.83%

ALPS Group Inc Ordinary Share Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALPS ALPS Group Inc Ordinary Share	0.9165 of 5 stars	$0.42 +33.4%	N/A	N/A	$69.87M	$4.86M	1.27	N/A	Short Interest Increase Gap Down High Trading Volume
NKTX Nkarta	3.4168 of 5 stars	$2.47 -2.8%	$11.20 +353.4%	+23.2%	$176.90M	N/A	N/A	140
CRBU Caribou Biosciences	1.7103 of 5 stars	$1.61 -1.8%	$7.75 +381.4%	-6.4%	$172.61M	$11.16M	N/A	100
MOLN Molecular Partners	3.3173 of 5 stars	$4.23 -2.3%	$8.38 +98.0%	+1.6%	$170.81M	$5.65M	N/A	180	News Coverage Positive News Earnings Report Short Interest Decrease Gap Up
MDWD MediWound	3.301 of 5 stars	$13.12 -3.5%	$33.00 +151.5%	-24.8%	$168.59M	$16.96M	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALPS) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ALPS Group Inc Ordinary Share (ALPS) Competitors

ALPS vs. NKTX, CRBU, MOLN, MDWD, and OKUR

How does ALPS Group Inc Ordinary Share compare to Nkarta?

Summary

How does ALPS Group Inc Ordinary Share compare to Caribou Biosciences?

Summary

How does ALPS Group Inc Ordinary Share compare to Molecular Partners?

Summary

How does ALPS Group Inc Ordinary Share compare to MediWound?

Summary

How does ALPS Group Inc Ordinary Share compare to OnKure Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALPS vs. The Competition

ALPS Group Inc Ordinary Share Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ALPS Group Inc Ordinary Share (ALPS) Competitors

ALPS vs. NKTX, CRBU, MOLN, MDWD, and OKUR

How does ALPS Group Inc Ordinary Share compare to Nkarta?

Which has more volatility and risk, ALPS or NKTX?

Does the media refer more to ALPS or NKTX?

Which has preferable valuation and earnings, ALPS or NKTX?

Do analysts rate ALPS or NKTX?

Do insiders & institutionals have more ownership in ALPS or NKTX?

Is ALPS or NKTX more profitable?

Summary

How does ALPS Group Inc Ordinary Share compare to Caribou Biosciences?

Which has more risk and volatility, CRBU or ALPS?

Which has preferable earnings and valuation, CRBU or ALPS?

Is CRBU or ALPS more profitable?

Do insiders and institutionals have more ownership in CRBU or ALPS?

Does the media refer more to CRBU or ALPS?

Do analysts prefer CRBU or ALPS?

Summary

How does ALPS Group Inc Ordinary Share compare to Molecular Partners?

Do institutionals and insiders have more ownership in ALPS or MOLN?

Do analysts prefer ALPS or MOLN?

Is ALPS or MOLN more profitable?

Which has better earnings & valuation, ALPS or MOLN?

Does the media refer more to ALPS or MOLN?

Which has more volatility & risk, ALPS or MOLN?

Summary

How does ALPS Group Inc Ordinary Share compare to MediWound?

Does the media prefer ALPS or MDWD?

Which has more volatility & risk, ALPS or MDWD?

Is ALPS or MDWD more profitable?

Which has stronger earnings and valuation, ALPS or MDWD?

Do institutionals & insiders believe in ALPS or MDWD?

Do analysts recommend ALPS or MDWD?

Summary

How does ALPS Group Inc Ordinary Share compare to OnKure Therapeutics?

Is ALPS or OKUR more profitable?

Which has more volatility and risk, ALPS or OKUR?

Does the media refer more to ALPS or OKUR?

Do analysts recommend ALPS or OKUR?

Which has preferable valuation and earnings, ALPS or OKUR?

Do institutionals and insiders hold more shares of ALPS or OKUR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALPS vs. The Competition

ALPS Group Inc Ordinary Share Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools